Mike Cordonnier, CEO of Carlsmed (CARL), explains how the company's AI-enabled platform is helping reduce re-operations in spinal surgery through personalized treatment planning. He details how AI and 3D-printed custom devices improve surgical outcomes while lowering costs for hospitals, supported by favorable Medicare reimbursement trends.